Quadruple adverse SARS-CoV-2-PCR: nonetheless COVID-19 pneumonia
Medical historical past and medical findings: A 78-year-old man fell sick with weak spot, coughing and fever 19 days after a cruise in early April 2020 and was admitted four days later with rising shortness of breath.
Examination and prognosis: On admission, the affected person had subfebrile temperatures, train dyspnea, and right-basal rales. CRP was reasonably elevated and oxygen saturation was barely decreased. Thoracic CT confirmed bilateral ground-glass infiltrates. Instantly after the cruise a nasopharyngeal swab was adverse for SARS-CoV-2.
Remedy and course: As a result of the truth that the affected person’s asymptomatic spouse had been examined constructive for SARS-CoV-2 instantly after coming back from the cruise, we suspected COVID-19 illness and admitted the affected person to our isolation ward. Two nasopharyngeal swabs and bronchial lavage yielded adverse outcomes for SARS-CoV-2. Lastly, suspected COVID-19 prognosis was verified serologically.
Conclusion: In case of a excessive diploma of medical suspicion together with typical findings of thoracic imaging, the suspected prognosis COVID-19 illness needs to be maintained even in case of a number of adverse SARS-CoV-2-PCR. Seroconversion happens a couple of days to 2 weeks after the onset of signs and can be utilized to substantiate the prognosis.
Anamnese und klinischer befund: Ein 78-jähriger Mann erkrankte Anfang April 2020 19 Tage nach einer Kreuzfahrt mit Schwäche, Husten und Fieber und wurde four Tage später mit zunehmender Luftnot vorstellig.
Untersuchung und diagnose: Bei Aufnahme bestanden subfebrile Temperaturen, Belastungsdyspnoe und rechtsbasale Rasselgeräusche. Das CRP struggle mäßig erhöht und die Sauerstoffsättigung gering reduziert. Im Thorax-CT fanden sich bilaterale Milchglasinfiltrate. Unmittelbar nach der Kreuzfahrt struggle ein nasopharyngealer Abstrich auf SARS-CoV-2 negativ.
Therapie und verlauf: In Kenntnis der Tatsache, dass die symptomfreie Ehefrau des Patienten unmittelbar nach Rückkehr von der Kreuzfahrt positiv auf SARS-CoV-2 getestet worden struggle, gingen wir von einer COVID-19-Erkrankung aus und hospitalisierten den Patienten. Zwei nasopharyngeale Abstriche und die Bronchiallavage ergaben adverse Befunde für SARS-CoV-2, die Diagnose COVID-19 wurde letztlich serologisch verifiziert.
Folgerung: Bei hochgradigem klinisch-anamnestischem Verdacht in Verbindung mit typischen Befunden der Thorax-Bildgebung sollte die Verdachtsdiagnose COVID-19 auch im Falle mehrfach negativer SARS-CoV-2-PCR aufrechterhalten bleiben. Die Serokonversion tritt einige Tage bis 2 Wochen nach Symptombeginn auf und kann im Verlauf zur endgültigen Diagnosesicherung genutzt werden.
Pancreatic Polypeptide |
|||
abx265640-100tests | Abbexa | 100 tests | EUR 975 |
Pancreatic Polypeptide |
|||
abx265640-200tests | Abbexa | 200 tests | EUR 1550 |
Pancreatic Polypeptide |
|||
abx265640-50tests | Abbexa | 50 tests | EUR 400 |
Pancreatic Polypeptide (31-36) |
|||
20-abx265274 | Abbexa |
|
|
Pancreatic Polypeptide (31-36) |
|||
abx265274-1mg | Abbexa | 1 mg | EUR 225 |
Pancreatic Polypeptide, rat |
|||
5-01709 | CHI Scientific | 4 x 1mg | Ask for price |
Pancreatic Polypeptide (rat) |
|||
4031085.05 | Bachem | 0.5 mg | EUR 280.88 |
Pancreatic Polypeptide (rat) |
|||
4031085.1 | Bachem | 1 mg | EUR 515.66 |
Pancreatic Polypeptide, rat |
|||
HY-P1532 | MedChemExpress | 5mg | EUR 1850.4 |
Pancreatic Polypeptide (rat) |
|||
H-6890.0500 | Bachem | 0.5mg | EUR 471.6 |
Description: Sum Formula: C195H298N58O57S; CAS# [90419-12-8] |
Pancreatic Polypeptide (rat) |
|||
H-6890.1000 | Bachem | 1.0mg | EUR 835.2 |
Description: Sum Formula: C195H298N58O57S; CAS# [90419-12-8] |
Pancreatic Polypeptide, rat |
|||
TP1044-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pancreatic Polypeptide, rat |
Pancreatic Polypeptide, rat |
|||
TP1044-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pancreatic Polypeptide, rat |
Pancreatic Polypeptide, rat |
|||
TP1044-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pancreatic Polypeptide, rat |
Pancreatic Polypeptide, rat |
|||
TP1044-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pancreatic Polypeptide, rat |
Pancreatic Polypeptide, rat |
|||
TP1044-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pancreatic Polypeptide, rat |
Pancreatic Polypeptide (Rat) |
|||
054-07 | PHOENIX PEPTIDE | 200 μg | EUR 135 |
Pancreatic Polypeptide, human |
|||
5-01708 | CHI Scientific | 4 x 1mg | Ask for price |
Pancreatic Polypeptide, avian |
|||
5-01712 | CHI Scientific | 0.4 x 5mg | Ask for price |
Pancreatic Polypeptide (human) |
|||
4015101.05 | Bachem | 0.5 mg | EUR 234.78 |
Pancreatic Polypeptide (human) |
|||
4015101.1 | Bachem | 1 mg | EUR 421.37 |
Pancreatic Polypeptide, avian |
|||
20-abx266528 | Abbexa |
|
|
Pancreatic Polypeptide (human) |
|||
B5060-.5 | ApexBio | 500 ?g | EUR 207 |
Description: Endogenous high affinity agonist for human NPY Y4 receptor |
Pancreatic Polypeptide (human) |
|||
B5060-1 | ApexBio | 1 mg | EUR 542 |
Description: Endogenous high affinity agonist for human NPY Y4 receptor |
Pancreatic Polypeptide (human) |
|||
B5060-5 | ApexBio | 5 mg | EUR 2117 |
Description: Endogenous high affinity agonist for human NPY Y4 receptor |
Pancreatic Polypeptide, human |
|||
HY-P0199 | MedChemExpress | 500ug | EUR 362.4 |
Pancreatic Polypeptide (human) |
|||
H-1610.0500 | Bachem | 0.5mg | EUR 400.8 |
Description: Sum Formula: C185H287N53O54S2; CAS# [75976-10-2] net |
Pancreatic Polypeptide (human) |
|||
H-1610.1000 | Bachem | 1.0mg | EUR 691.2 |
Description: Sum Formula: C185H287N53O54S2; CAS# [75976-10-2] net |
Pancreatic Polypeptide (human) |
|||
SP-100447-1 | Alpha Diagnostics | 1 mg | EUR 416.4 |
Pancreatic Polypeptide, human |
|||
TP1137-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pancreatic Polypeptide, human |
Pancreatic Polypeptide, human |
|||
TP1137-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pancreatic Polypeptide, human |
Pancreatic Polypeptide, human |
|||
TP1137-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pancreatic Polypeptide, human |
Pancreatic Polypeptide, human |
|||
TP1137-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pancreatic Polypeptide, human |
Pancreatic Polypeptide, human |
|||
TP1137-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pancreatic Polypeptide, human |
Pancreatic Polypeptide (Avian) |
|||
054-01 | PHOENIX PEPTIDE | 200 μg | EUR 135 |
Pancreatic Polypeptide (Human) |
|||
054-02 | PHOENIX PEPTIDE | 200 μg | EUR 135 |
Pancreatic Polypeptide, avian |
|||
abx266528-1ml | Abbexa | 1 ml | EUR 437.5 |
Pancreatic Polypeptide, avian |
|||
abx266528-200l | Abbexa | 200 µl | EUR 300 |
Pancreatic Polypeptide (bovine) |
|||
5-01706 | CHI Scientific | 4 x 1mg | Ask for price |
Pancreatic Polypeptide (bovine) |
|||
4012218.05 | Bachem | 0.5 mg | EUR 280.88 |
Pancreatic Polypeptide (bovine) |
|||
4012218.1 | Bachem | 1 mg | EUR 505.58 |
Pancreatic Polypeptide, bovine |
|||
HY-P1537 | MedChemExpress | 1mg | EUR 514.8 |
Pancreatic Polypeptide (bovine) |
|||
H-6610.0500 | Bachem | 0.5mg | EUR 471.6 |
Description: Sum Formula: C186H287N53O56S2; CAS# [179986-89-1] |
Pancreatic Polypeptide (bovine) |
|||
H-6610.1000 | Bachem | 1.0mg | EUR 819.6 |
Description: Sum Formula: C186H287N53O56S2; CAS# [179986-89-1] |
Pancreatic Polypeptide (bovine) |
|||
SP-100446-1 | Alpha Diagnostics | 1 mg | EUR 416.4 |
Pancreatic Polypeptide, bovine |
|||
TP1731-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pancreatic Polypeptide, bovine |
Pancreatic Polypeptide, bovine |
|||
TP1731-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pancreatic Polypeptide, bovine |
Pancreatic Polypeptide, bovine |
|||
TP1731-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pancreatic Polypeptide, bovine |
Pancreatic Polypeptide, bovine |
|||
TP1731-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pancreatic Polypeptide, bovine |
Pancreatic Polypeptide, bovine |
|||
TP1731-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pancreatic Polypeptide, bovine |
Pancreatic Polypeptide (Salmon) |
|||
054-09 | PHOENIX PEPTIDE | 200 μg | EUR 177.12 |
Pancreatic Polypeptide (Biotin) |
|||
abx265268-10mg | Abbexa | 10 mg | EUR 1200 |
Pancreatic Polypeptide (Biotin) |
|||
abx265268-1mg | Abbexa | 1 mg | EUR 325 |
Pancreatic Polypeptide (Biotin) |
|||
abx265268-5mg | Abbexa | 5 mg | EUR 762.5 |
Pancreatic Polypeptide antibody |
|||
10-1766 | Fitzgerald | 200 ul | EUR 1475 |
Description: Mouse monoclonal Pancreatic Polypeptide antibody |
Pancreatic Polypeptide Antibody |
|||
abx430988-200ul | Abbexa | 200 ul | EUR 460.8 |
Pancreatic Polypeptide Antibody |
|||
DF13387 | Affbiotech | 100ul | EUR 420 |
Pancreatic Polypeptide Antibody |
|||
DF13387-100ul | Affinity Biosciences | 100ul | EUR 280 |
Pancreatic Polypeptide Antibody |
|||
DF13387-200ul | Affinity Biosciences | 200ul | EUR 350 |
Pancreatic Polypeptide antibody |
|||
70R-51950 | Fitzgerald | 100 ug | EUR 610 |
Description: Goat polyclonal Pancreatic Polypeptide antibody |
Pancreatic Polypeptide Antibody |
|||
R36274-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
Description: Additional name(s) for this target protein: Pancreatic polypeptide Y; PPY |
Pancreatic Polypeptide Antibody |
|||
abx430988-200l | Abbexa | 200 µl | EUR 387.5 |
Pancreatic Polypeptide (31-36) (human) |
|||
5-01710 | CHI Scientific | 4 x 5mg | Ask for price |
Pancreatic Polypeptide (31-36) (human) |
|||
SP-100449-1 | Alpha Diagnostics | 1 mg | EUR 196.8 |
Pancreatic Polypeptide (PP) Antibody |
|||
20-abx128563 | Abbexa |
|
|
Pancreatic Polypeptide (PP) Antibody |
|||
20-abx129549 | Abbexa |
|
|
Pancreatic Polypeptide (PP) Antibody |
|||
20-abx173944 | Abbexa |
|
|
Pancreatic Polypeptide (PP) Antibody |
|||
20-abx173945 | Abbexa |
|
|
Pancreatic Polypeptide (PP) Antibody |
|||
20-abx177910 | Abbexa |
|
|
Pancreatic Polypeptide (PP) Antibody |
|||
20-abx177911 | Abbexa |
|
|
Pancreatic Polypeptide Peptide (OVA) |
|||
20-abx165589 | Abbexa |
|
|
Pancreatic Polypeptide, rat acetate |
|||
TP1044L-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pancreatic Polypeptide, rat acetate |
Pancreatic Polypeptide, rat acetate |
|||
TP1044L-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pancreatic Polypeptide, rat acetate |
Pancreatic Polypeptide, rat acetate |
|||
TP1044L-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pancreatic Polypeptide, rat acetate |
Pancreatic Polypeptide, rat acetate |
|||
TP1044L-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pancreatic Polypeptide, rat acetate |
Pancreatic Polypeptide, rat acetate |
|||
TP1044L-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pancreatic Polypeptide, rat acetate |
Pancreatic Polypeptide (PP) Antibody |
|||
abx128563-100l | Abbexa | 100 µl | EUR 262.5 |
Pancreatic Polypeptide (PP) Antibody |
|||
abx128563-1ml | Abbexa | 1 ml | EUR 712.5 |
Pancreatic Polypeptide (PP) Antibody |
|||
abx128563-200l | Abbexa | 200 µl | EUR 325 |
Pancreatic Polypeptide (PP) Antibody |
|||
abx129549-100l | Abbexa | 100 µl | EUR 262.5 |
Pancreatic Polypeptide (PP) Antibody |
|||
abx129549-1ml | Abbexa | 1 ml | EUR 725 |
Pancreatic Polypeptide (PP) Antibody |
|||
abx129549-200l | Abbexa | 200 µl | EUR 337.5 |
Pancreatic Polypeptide (PP) Antibody |
|||
abx173944-100l | Abbexa | 100 µl | EUR 750 |
Pancreatic Polypeptide (PP) Antibody |
|||
abx173944-1ml | Abbexa | 1 ml | Ask for price |
Pancreatic Polypeptide (PP) Antibody |
|||
abx173944-200l | Abbexa | 200 µl | Ask for price |
Synthetic Pancreatic Polypeptide (PP) |
|||
RPU55425-100ug | Biomatik Corporation | 100ug | EUR 369.6 |
Synthetic Pancreatic Polypeptide (PP) |
|||
RPU55425-1mg | Biomatik Corporation | 1mg | EUR 1638 |
Synthetic Pancreatic Polypeptide (PP) |
|||
RPU55425-50ug | Biomatik Corporation | 50ug | EUR 297 |
Synthetic Pancreatic Polypeptide (PP) |
|||
4-SPB265Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Pancreatic Polypeptide expressed in: E.coli |
Shifting from qPCR to Chip Digital PCR Assays for Monitoring of some Fusarium Species Inflicting Fusarium Head Blight in Cereals
Fusarium Head Blight (FHB) is without doubt one of the main illnesses affecting small-grain cereals, worldwide unfold and chargeable for extreme yield and high quality losses yearly. Diagnostic instruments, in a position to monitor Fusarium species even within the early levels of an infection, can contribute to mycotoxins’ threat management.
Amongst DNA-based applied sciences for Fusarium detection, qPCR (single and multiplex assays) is at present essentially the most utilized methodology. Nonetheless, pathogen diagnostics is now enforced by digital PCR (dPCR), a breakthrough expertise that gives ultrasensitive and absolute nucleic acid quantification. In our work, a panel of chip digital PCR assays was developed to quantify Fusarium graminearum, F.culmorum, F. sporotrichioides, F. poae and F. avenaceum.
The primers/probes mixtures had been evaluated on pure fungal samples with cdPCR method, compared with the qPCR method. Furthermore, the cdPCR assays had been utilized to quantify Fusarium in durum wheat and oat samples, naturally contaminated or spiked with fungal DNA.
For a greater analysis of an infection stage in vegetation, duplex assays had been developed, in a position to co-amplify each plant and fungal DNA. To the most effective of our information, that is the primary research directed to the applying of digital PCR to Fusarium prognosis in vegetation.
Prognosis of SARS-CoV-2 by RT-PCR Utilizing Completely different Pattern Sources: Evaluation of the Literature
Goal: Probably the most broadly used diagnostic method for extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an infection is real-time reverse transcriptase-polymerase chain response (RT-PCR). It may be achieved on completely different samples: nasopharyngeal swabs (NPS) or oropharyngeal swabs (OPS), and self-collected saliva. Nonetheless, adverse findings don’t rule out an infection.
Strategies: A overview was conceived to debate benefits and limitations of the obtainable diagnostic modalities for nonserologic prognosis of SARS-CoV-2 primarily based on RT-PCR; the article additionally proposes some sensible recommendations to enhance diagnostic reliability.
Outcomes: A complete of 16 papers (equivalent to 452 sufferers) of the 56 initially recognized had been included. Many of the papers describe findings from completely different samples obtained in restricted case collection; comparative research are lacking.
Conclusions: Diagnostic accuracy of NPS and OPS is suboptimal and the danger of contaminated aerosol dispersal is just not negligible. The SARS-CoV-2 RNA could be present in self-collected saliva specimens of many contaminated sufferers inside 7 to 10 days after symptom onset.
There may be an pressing want for comparative trials to outline the diagnostic modality of selection. Ample training and coaching of well being care personnel is necessary.
GPCR GPR86 Antibody |
|||
48382 | SAB | 100ul | EUR 429 |
GPCR GPR86 Antibody |
|||
48382-100ul | SAB | 100ul | EUR 399.6 |
GPCR GPR86 Antibody |
|||
48382-50ul | SAB | 50ul | EUR 286.8 |
GPCR GPR65 Antibody |
|||
DF13937 | Affbiotech | 100ul | EUR 420 |
GPCR GPR65 Antibody |
|||
DF13937-100ul | Affinity Biosciences | 100ul | EUR 280 |
GPCR GPR65 Antibody |
|||
DF13937-200ul | Affinity Biosciences | 200ul | EUR 350 |
GPCR LS19072 Antibody |
|||
GWB-800006 | GenWay Biotech | 0.025 mg | Ask for price |
Anti-GPR151/Gpcr 2037 Antibody |
|||
A30814 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal GPR151/Gpcr 2037 Antibody. Validated in IF, WB and tested in Mouse, Rat. |
Anti-GPR151/Gpcr 2037 Antibody |
|||
A14582 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal GPR151/Gpcr 2037 Antibody. Validated in WB and tested in Human, Mouse, Rat. |
GPCR RDC1 Conjugated Antibody |
|||
C49041 | SAB | 100ul | EUR 476.4 |
GPCR GPR86 Conjugated Antibody |
|||
C48382 | SAB | 100ul | EUR 476.4 |
Anti-LGR6/Gpcr Lgr6 Antibody |
|||
A05990 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal LGR6/Gpcr Lgr6 Antibody. Validated in IHC and tested in Human, Mouse, Rat. |
INSL5 Receptor / GPCR-142 (310-330) (Human) - Antibody |
|||
H-001-86 | PHOENIX PEPTIDE | 100 μl | EUR 604.8 |
GPCR EX33 |
|||
E8ER1909-85 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
GPCR RDC1 |
|||
E8ET1611-3 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
GPCR GPR86 |
|||
E8EM1706-13 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
GPCR-135 (390-416) |
|||
001-85 | PHOENIX PEPTIDE | 100 μg | EUR 316.44 |
GPCR MRGX2 (MRGPRX2) mouse monoclonal antibody, clone 1D3, Purified |
|||
AM26724PU-N | Origene Technologies GmbH | 100 µg | Ask for price |
[Cys0]-GPCR-135 (438-469) |
|||
001-84 | PHOENIX PEPTIDE | 100 μg | EUR 316.44 |
[Cys0]-GPCR-142 (351-374) |
|||
001-87 | PHOENIX PEPTIDE | 100 μg | EUR 282.96 |
anti-5-oxo-ETE GPCR |
|||
YF-PA22585 | Abfrontier | 50 ug | EUR 435.6 |
Description: Mouse polyclonal to 5-oxo-ETE GPCR |
GPCR MRGX2 (MRGPRX2) (C-term) rabbit polyclonal antibody, Aff - Purified |
|||
AP52746PU-N | Origene Technologies GmbH | 400 µl | Ask for price |
GPCR-2037, C-terminal (Rat) |
|||
001-99 | PHOENIX PEPTIDE | 100 μg | EUR 282.96 |
GPCR-2037, C-terminal (Mouse) |
|||
001-41 | PHOENIX PEPTIDE | 100 μg | EUR 316.44 |
Rat GPCR ELISA Kit |
|||
ERG0026 | Abclonal | 96Tests | EUR 625.2 |
[Cys0]-GPCR-56 (658-693) (Human) |
|||
001-35 | PHOENIX PEPTIDE | 100 μg | EUR 316.44 |
Goat GPCR ELISA Kit |
|||
EGTG0026 | Abclonal | 96Tests | EUR 625.2 |
Human GPCR ELISA Kit |
|||
EHG0026 | Abclonal | 96Tests | EUR 625.2 |
GPCR / LGR6 Rabbit mAb |
|||
56659 | SAB | 100ul | EUR 339 |
Sheep GPCR ELISA Kit |
|||
ESG0026 | Abclonal | 96Tests | EUR 625.2 |
Mouse GPCR ELISA Kit |
|||
EMG0026 | Abclonal | 96Tests | EUR 625.2 |
Bovine GPCR ELISA Kit |
|||
EBG0026 | Abclonal | 96Tests | EUR 625.2 |
Canine GPCR ELISA Kit |
|||
ECG0026 | Abclonal | 96Tests | EUR 625.2 |
Monkey GPCR ELISA Kit |
|||
EMKG0026 | Abclonal | 96Tests | EUR 625.2 |
Rabbit GPCR ELISA Kit |
|||
ERTG0026 | Abclonal | 96Tests | EUR 625.2 |
Chicken GPCR ELISA Kit |
|||
ECKG0026 | Abclonal | 96Tests | EUR 625.2 |
Porcine GPCR ELISA Kit |
|||
EPG0026 | Abclonal | 96Tests | EUR 625.2 |
[Cys0]-GPCR-2037, C-terminal (Human) |
|||
001-96 | PHOENIX PEPTIDE | 100 μg | EUR 282.96 |
Guinea Pig GPCR ELISA Kit |
|||
EGG0026 | Abclonal | 96Tests | EUR 625.2 |
GPCR 154, Isoform B (357-377) (Human) |
|||
001-34 | PHOENIX PEPTIDE | 100 μg | EUR 177.12 |
DiscoveryProbe? GPCR Compound Library |
|||
L1025-5 | ApexBio | 5 mg/well | EUR 13284 |
Anserini GPCR-APJ ELISA Kit |
|||
EAG0026 | Abclonal | 96Tests | EUR 625.2 |
DiscoveryProbe™ GPCR Compound Library |
|||
L1025-.096 | ApexBio | 100uL/well(10 mM solution),96 Well Deep Well Plate | EUR 4334 |
Description: A unique collection of 931 GPCR-related small molecules for GPCR screening. |
DiscoveryProbe™ GPCR Compound Library |
|||
L1025-.1 | ApexBio | 100 uL/well(10 mM solution) | EUR 5413 |
Description: A unique collection of 931 GPCR-related small molecules for GPCR screening. |
DiscoveryProbe™ GPCR Compound Library |
|||
L1025-.25 | ApexBio | 250 uL/well(10 mM solution) | EUR 9780 |
Description: A unique collection of 931 GPCR-related small molecules for GPCR screening. |
Orphan GPCR SP9155 Agonist P518 (human) |
|||
4043081.05 | Bachem | 0.5 mg | EUR 356.16 |
Orphan GPCR SP9155 Agonist P518 (human) |
|||
4043081.1 | Bachem | 1 mg | EUR 637.04 |
Orphan GPCR SP9155 Agonist P518 (human) |
|||
H-5984.0500 | Bachem | 0.5mg | EUR 588 |
Description: Sum Formula: C127H195N37O37; CAS# [600171-68-4] net |
Orphan GPCR SP9155 Agonist P518 (human) |
|||
H-5984.1000 | Bachem | 1.0mg | EUR 1023.6 |
Description: Sum Formula: C127H195N37O37; CAS# [600171-68-4] net |
Orphan GPCR SP9155 Agonist P550 (mouse) |
|||
H-5986.0500 | Bachem | 0.5mg | EUR 588 |
Description: Sum Formula: C126H195N37O37; CAS# [600171-70-8] net |
Orphan GPCR SP9155 Agonist P550 (mouse) |
|||
H-5986.1000 | Bachem | 1.0mg | EUR 1023.6 |
Description: Sum Formula: C126H195N37O37; CAS# [600171-70-8] net |
GPCR Ligand Screening related services & products |
|||
fAP-0028 | Angio Proteomie | Service | Ask for price |
Orphan GPCR SP9155 agonist P550 (mouse, rat) |
|||
T40685-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) |
Orphan GPCR SP9155 agonist P550 (mouse, rat) |
|||
T40685-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) |
Orphan GPCR SP9155 agonist P550 (mouse, rat) |
|||
T40685-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) |
Orphan GPCR SP9155 agonist P550 (mouse, rat) |
|||
T40685-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) |
Orphan GPCR SP9155 agonist P550 (mouse, rat) |
|||
T40685-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) |
Anti-D-GPCR Antibody |
|||
A12058 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal Antibody for D-GPCR Antibody (OR51E1) detection.tested for WB in Human. |
Anti-D-GPCR antibody |
|||
STJ92705 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to D-GPCR. |
Anti-GPCR GPR3 Antibody |
|||
STJ501253 | St John's Laboratory | 100 µg | EUR 571.2 |
Anti-GPCR GPR40 Antibody |
|||
STJ501005 | St John's Laboratory | 100 µg | EUR 571.2 |
D-GPCR Polyclonal Antibody |
|||
ABP51168-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of D-GPCR from Human. This D-GPCR antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human D-GPCR at AA range: 210-290 |
D-GPCR Polyclonal Antibody |
|||
ABP51168-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of D-GPCR from Human. This D-GPCR antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human D-GPCR at AA range: 210-290 |
D-GPCR Polyclonal Antibody |
|||
ABP51168-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of D-GPCR from Human. This D-GPCR antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human D-GPCR at AA range: 210-290 |
D-GPCR Polyclonal Antibody |
|||
E20-71340 | EnoGene | 100ug | EUR 225 |
Description: Available in various conjugation types. |
D-GPCR Polyclonal Antibody |
|||
E44H04518 | EnoGene | 100ul | EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
AAP41265-100UG - GPCR Peptide - C-terminal region |
|||
AAP41265-100UG | Aviva Systems Biology | 100ug | EUR 99 |
GPCR135 Antibody |
|||
E38PA5050 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
GPCR19 Antibody |
|||
20-abx121119 | Abbexa |
|
|
GPCR19 Antibody |
|||
47886 | SAB | 100ul | EUR 319 |
GPCR19 Antibody |
|||
47886-100ul | SAB | 100ul | EUR 302.4 |
GPCR19 Antibody |
|||
E047886 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
GPCR19 Antibody |
|||
E38PA3618 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Human G Protein Coupled Receptor(GPCR) Elisa Kit |
|||
EK711735 | AFG Bioscience LLC | 96 Wells | EUR 0.2 |
Human G Protein Coupled Receptor(GPCR) ELISA Kit |
|||
SL2225Hu | Sunlong | 96 Tests | EUR 468 |
DiscoveryProbe? GPCR/G protein-related Compounds Panel |
|||
L1009-5 | ApexBio | 5 mg/well | EUR 7242 |
Description: A wide range of well-characterized bioactive molecules that covers various targets related to GPCR, including adenosine receptor, adrenergic receptor and CXCR etc. Facilitate your research towards the insights of cancer, neurological disorders and heart diseases etc. |
Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
|||
T40685L-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
|||
T40685L-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
|||
T40685L-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
|||
T40685L-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
|||
T40685L-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate |
Anti-GPCR GPR3 Antibody FITC |
|||
STJ501255 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-GPCR LGR8/RXFP2 Antibody |
|||
A04848-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-GPCR GPR40 Antibody FITC |
|||
STJ501007 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-GPCR GPR7/NPBWR1 Antibody |
|||
A08247-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-GPCR GPR40/FFAR1 Antibody |
|||
A01349-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-GPCR GPR3 Antibody BIOTIN |
|||
STJ501254 | St John's Laboratory | 100 µg | EUR 703.2 |
Polyclonal GPCR135 Antibody |
|||
AMM05178G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCR135 . This antibody is tested and proven to work in the following applications: |
Anti-GPCR GPR40 Antibody BIOTIN |
|||
STJ501006 | St John's Laboratory | 100 µg | EUR 703.2 |
G-Protein Coupled Receptor (GPCR) Peptide Ligand Library |
|||
L-004 | PHOENIX PEPTIDE | 935 peptides | EUR 29601.72 |
Anti-GPR12/Gpcr12 Antibody |
|||
A10818 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal GPR12/Gpcr12 Antibody. Validated in IF and tested in Human. |
Anti-GPR160/Gpcr150 Antibody |
|||
A14818 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal GPR160/Gpcr150 Antibody. Validated in WB and tested in Human. |
GPCR5A antibody |
|||
70R-6472 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal GPCR5A antibody raised against the C terminal Of Gpcr5A |
GPCR5A Antibody |
|||
GWB-D542BF | GenWay Biotech | 0.05 mg | Ask for price |
D-GPCR Rabbit Polyclonal Antibody |
|||
ES2167-100ul | ELK Biotech | 100ul | EUR 124 |
Description: A Rabbit Polyclonal antibody against D-GPCR from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
D-GPCR Rabbit Polyclonal Antibody |
|||
ES2167-50ul | ELK Biotech | 50ul | EUR 74 |
Description: A Rabbit Polyclonal antibody against D-GPCR from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
Cell Meterâ„¢ Beta-Arrestin Translocation GPCR Signaling Kit |
|||
36390-100Tests | AAT Bioquest | 100 Tests | EUR 781 |
Description: Virtually all G protein coupled receptors (GPCRs) rapidly undergo desensitization by a common pathway upon activation by ligand binding. |
Cell Meterâ„¢ Beta-Arrestin Translocation GPCR Signaling Kit |
|||
36391-200Tests | AAT Bioquest | 200 Tests | EUR 989 |
Description: Virtually all G protein coupled receptors (GPCRs) rapidly undergo desensitization by a common pathway upon activation by ligand binding. |
G-Protein Coupled Receptor GPCR135 (GPCR135) Antibody |
|||
20-abx133555 | Abbexa |
|
|
GPCR19 Conjugated Antibody |
|||
C47886 | SAB | 100ul | EUR 476.4 |
Anti-GPCR RDC1/CXCR-7 Antibody |
|||
R1512-3 | HUABIO | 100ul | EUR 189 |
Description: Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Acts as a receptor for chemokines CXCL11 and CXCL12/SDF1. Chemokine binding does not activate G-protein-mediated signal transduction but instead induces beta-arrestin recruitment, leading to ligand internalization and activation of MAPK signaling pathway. Required for regulation of CXCR4 protein levels in migrating interneurons, thereby adapting their chemokine responsiveness. In glioma cells, transduces signals via MEK/ERK pathway, mediating resistance to apoptosis. Promotes cell growth and survival. Not involved in cell migration, adhesion or proliferation of normal hematopoietic progenitors but activated by CXCL11 in malignant hemapoietic cells, leading to phosphorylation of ERK1/2 (MAPK3/MAPK1) and enhanced cell adhesion and migration. Plays a regulatory role in CXCR4-mediated activation of cell surface integrins by CXCL12. Required for heart valve development. Acts as coreceptor with CXCR4 for a restricted number of HIV isolates. |
Rabbit anti GPCR119 Polyclonal Antibody |
|||
TA354528 | Origene Technologies GmbH | 100 µg | Ask for price |
HEK293 Cells Stable expressing GPCR protein MAS1 (Protein accession # NM_002377) |
|||
cAP-1280 | Angio Proteomie | 2Frozen Vial | EUR 11880 |
HEK293 Cells Stable expressing GPCR protein CXCR4 (Protein accession # NM_003467) |
|||
cAP-1101 | Angio Proteomie | 2Frozen Vial | EUR 11880 |
Anti-GPCR TGR5/GPBAR1 Antibody Picoband™ |
|||
A01958-1 | BosterBio | 10ug | EUR 154 |
Description: Western blot, 0.25-0.5μg/ml, Mouse, Rat |
Anti-GPCR TGR5/GPBAR1 Antibody Picoband™ |
|||
A01958-2 | BosterBio | 10ug | EUR 154 |
Description: Western blot, 0.25-0.5 μg/ml, Mouse, Rat;_x000D_Flow Cytometry, 1-3 μg/1x106 cells, Human;_x000D_Direct ELISA, 0.1-0.5 μg/ml, Human |
Anti- G Protein-Coupled Receptor GPR160/GPCR150 Human Antibody |
|||
GWB-84AB9F | GenWay Biotech | 0.05 mg | Ask for price |
Interleukin 15 (IL-15) Antibody |
|||
abx432855-200ul | Abbexa | 200 ul | EUR 460.8 |
Interleukin 15 (IL-15) Antibody |
|||
abx432855-100g | Abbexa | 100 µg | EUR 387.5 |
Polyclonal GPCR6 / GPR101 Antibody (aa451-500) |
|||
APR16465G | Leading Biology | 0.05ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCR6 / GPR101 (aa451-500). This antibody is tested and proven to work in the following applications: |
GPCR150 (GPR160) (C-term) rabbit polyclonal antibody, Aff - Purified |
|||
AP51922PU-N | Origene Technologies GmbH | 400 µl | Ask for price |
Cytokeratin 15 (Cytokeratin 15) Antibody |
|||
20-abx225265 | Abbexa |
|
|
Cytokeratin 15 (Cytokeratin 15) Antibody |
|||
abx232198-100ug | Abbexa | 100 ug | EUR 577.2 |
Cytokeratin 15 (Cytokeratin 15) Antibody |
|||
abx232199-100ug | Abbexa | 100 ug | EUR 610.8 |
GPCR150 (GPR160) (3rd Cytpl. Dom.) rabbit polyclonal antibody, Aff - Purified |
|||
AP06977PU-N | Origene Technologies GmbH | 50 µg | Ask for price |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HRH4 (Protein accession # NM_001143828) |
|||
cAP-1244 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HRH4 (Protein accession # NM_021624) |
|||
cAP-1245 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR4 (Protein accession # NM_199453) |
|||
cAP-1254 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR4 (Protein accession # NM_000870) |
|||
cAP-1255 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR4 (Protein accession # NM_001040172) |
|||
cAP-1256 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR4 (Protein accession # NM_001040169) |
|||
cAP-1257 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR4 (Protein accession # NM_001040173) |
|||
cAP-1258 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR6 (Protein accession # NM_000871) |
|||
cAP-1260 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR7 (Protein accession # NM_000872) |
|||
cAP-1261 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR7 (Protein accession # NM_019860) |
|||
cAP-1262 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein HTR7 (Protein accession # NM_019859) |
|||
cAP-1263 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein LGR4 (Protein accession # NM_018490) |
|||
cAP-1265 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein LGR5 (Protein accession # NM_003667) |
|||
cAP-1266 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein MC1R (Protein accession # NM_002386) |
|||
cAP-1281 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein MC2R (Protein accession # NM_000529) |
|||
cAP-1282 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein MC3R (Protein accession # NM_019888) |
|||
cAP-1283 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein MC4R (Protein accession # NM_005912) |
|||
cAP-1284 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein NMBR (Protein accession # NM_002511) |
|||
cAP-1292 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein OPN3 (Protein accession # NM_014322) |
|||
cAP-1303 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein OXTR (Protein accession # NM_000916) |
|||
cAP-1328 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein RGR (Protein accession # NM_001012722) |
|||
cAP-1373 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein RGR (Protein accession # NM_001012720) |
|||
cAP-1374 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein RGR (Protein accession # NM_002921) |
|||
cAP-1375 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein TRHR (Protein accession # NM_003301) |
|||
cAP-1411 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein TSHR (Protein accession # NM_001142626) |
|||
cAP-1412 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein TSHR (Protein accession # NM_000369) |
|||
cAP-1413 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein XCR1 (Protein accession # NM_001024644) |
|||
cAP-1418 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein XCR1 (Protein accession # NM_005283) |
|||
cAP-1419 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein BRS3 (Protein accession # NM_001727) |
|||
cAP-1052 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CASR (Protein accession # NM_000388) |
|||
cAP-1060 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR1 (Protein accession # NM_001295) |
|||
cAP-1062 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR2 (Protein accession # NM_000647) |
|||
cAP-1064 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR2 (Protein accession # NM_000648) |
|||
cAP-1065 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR3 (Protein accession # NM_178329) |
|||
cAP-1066 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR3 (Protein accession # NM_001164680) |
|||
cAP-1067 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR3 (Protein accession # NM_178328) |
|||
cAP-1068 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR3 (Protein accession # NM_001837) |
|||
cAP-1069 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR4 (Protein accession # NM_005508) |
|||
cAP-1070 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR5 (Protein accession # NM_000579) |
|||
cAP-1071 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR6 (Protein accession # NM_004367) |
|||
cAP-1072 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR6 (Protein accession # NM_031409) |
|||
cAP-1073 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR7 (Protein accession # NM_001838) |
|||
cAP-1074 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR8 (Protein accession # NM_005201) |
|||
cAP-1075 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CCR9 (Protein accession # NM_006641) |
|||
cAP-1076 | Angio Proteomie | 1Frozen Vial | EUR 11880 |
CHO-K1/HEK293 Cells Stable expressing GPCR protein CNR1 (Protein accession # NM_016083) |
|||
cAP-1084 | Angio Proteomie | 1Frozen Vial | EUR 11880 |